Publication Date
11-1-2022
Journal
Circulation: Cardiovascular Imaging
DOI
10.1161/CIRCIMAGING.121.013676
PMID
36378780
PMCID
PMC9674374
PubMedCentral® Posted Date
11-15-2023
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes
Keywords
Humans, Echocardiography, Sulfonamides, Pyrimidines, Diastole, Ventricular Function, Left, Fontan, echocardiography, cardiopulmonary exercise test, phosphodiestherase-5-inhibitor, Congenital Heart Disease, Echocardiography, Exercise
Abstract
BACKGROUND: The FUEL trial (Fontan Udenafil Exercise Longitudinal) demonstrated statistical improvements in exercise capacity following 6 months of treatment with udenafil (87.5 mg po BID). The effect of udenafil on echocardiographic measures of single ventricle function in this cohort has not been studied.
METHODS: The 400 enrolled participants were randomized 1:1 to udenafil or placebo. Protocol echocardiograms were obtained at baseline and 26 weeks after initiation of udenafil/placebo. Linear regression compared change from baseline indices of single ventricle systolic, diastolic and global function, atrioventricular valve regurgitation, and mean Fontan fenestration gradient in the udenafil cohort versus placebo, controlling for ventricular morphology (left ventricle versus right ventricle/other) and baseline value.
RESULTS: The udenafil participants (n=191) had significantly improved between baseline and 26 weeks visits compared to placebo participants (n=195) in myocardial performance index (
CONCLUSIONS: FUEL participants who received udenafil demonstrated a statistically significant improvement in some global and diastolic echo indices. Although small, the changes in diastolic function suggest improvement in pulmonary venous return and/or augmented ventricular compliance, which may help explain improved exercise performance in that cohort.
Clinical Trial Registration Information: ClinicalTrials.gov Identifier: NCT02741115; https://clinicaltrials.gov/ct2/show/NCT02741115
Included in
Cardiology Commons, Cardiovascular Diseases Commons, Congenital, Hereditary, and Neonatal Diseases and Abnormalities Commons, Medical Sciences Commons, Pediatrics Commons